Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Comment by ronzon Apr 13, 2007 9:28am
336 Views
Post# 12600226

RE: FDA advisers reject Vioxx successor

RE: FDA advisers reject Vioxx successorI wondered that myself, but that would have been a factor only if Merk was our potential partner and they would not have needed Pennsaid if the other drug had been approved since they felt that this latest drug was their next potential blockbuster. What this does do is suggests that the FDA is looking for some other form of drug that is safer to use for pain and by their own statements that sure sounds a lot to me like Pennsaid would fit in perfectly. With a proper partner, approval, and a big advertising campain, Pennsaid would be a wonder drug for many people and they would be able to advertise the safety benifits over the risks associated with the likes of the other ostioarthritis drugs.
Bullboard Posts